123 related articles for article (PubMed ID: 12532181)
1. Topical tacrolimus Protopic.
Lazarous MC; Kerdel FA
Drugs Today (Barc); 2002 Jan; 38(1):7-15. PubMed ID: 12532181
[TBL] [Abstract][Full Text] [Related]
2. Potential future dermatological indications for tacrolimus ointment.
Ruzicka T; Assmann T; Lebwohl M
Eur J Dermatol; 2003; 13(4):331-42. PubMed ID: 12948911
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus in dermatology-pharmacokinetics, mechanism of action, drug interactions, dosages, and side effects: part I.
Sehgal VN; Srivastava G; Dogra S
Skinmed; 2008; 7(1):27-30. PubMed ID: 18174798
[TBL] [Abstract][Full Text] [Related]
4. NK-cell activity in immunotoxicity drug evaluation.
Cederbrant K; Marcusson-Ståhl M; Condevaux F; Descotes J
Toxicology; 2003 Apr; 185(3):241-50. PubMed ID: 12581699
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus in dermatologic disorders.
Skaehill PA
Ann Pharmacother; 2001 May; 35(5):582-8. PubMed ID: 11346066
[TBL] [Abstract][Full Text] [Related]
6. Use of pimecrolimus cream in disorders other than atopic dermatitis.
Day I; Lin AN
J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
[TBL] [Abstract][Full Text] [Related]
7. Systemic ciclosporin and tacrolimus in dermatology.
Madan V; Griffiths CE
Dermatol Ther; 2007; 20(4):239-50. PubMed ID: 17970889
[TBL] [Abstract][Full Text] [Related]
8. Potential new indications of topical calcineurin inhibitors.
Luger T; Paul C
Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
[TBL] [Abstract][Full Text] [Related]
9. Topical tacrolimus and pimecrolimus: future directions.
Ling MR
Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical calcineurin inhibitors in lichen planus.
Samycia M; Lin AN
J Cutan Med Surg; 2012; 16(4):221-9. PubMed ID: 22784514
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus.
Hodgson TA; Sahni N; Kaliakatsou F; Buchanan JA; Porter SR
Eur J Dermatol; 2003; 13(5):466-70. PubMed ID: 14693491
[TBL] [Abstract][Full Text] [Related]
12. Topical tacrolimus: a new therapy for atopic dermatitis.
Russell JJ
Am Fam Physician; 2002 Nov; 66(10):1899-902. PubMed ID: 12469964
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Hultsch T; Kapp A; Spergel J
Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus.
Frankel SJ; Kerdel FA
Skin Therapy Lett; 2001; 6(4):1-2, 5. PubMed ID: 11176043
[TBL] [Abstract][Full Text] [Related]
15. Treatment of erosive oral lichen planus with topical tacrolimus.
Thomson MA; Hamburger J; Stewart DG; Lewis HM
J Dermatolog Treat; 2004 Sep; 15(5):308-14. PubMed ID: 15370399
[TBL] [Abstract][Full Text] [Related]
16. Topical tacrolimus in the management of oral lichen planus: literature review.
Shilpa PS; Kaul R; Bhat S; Sanjay CJ; Sultana N
J Calif Dent Assoc; 2014 Mar; 42(3):165-70. PubMed ID: 25080722
[TBL] [Abstract][Full Text] [Related]
17. [The use of tacrolimus in dermatology].
Slodownik D; Ingber A
Harefuah; 2003 Nov; 142(11):770-4, 805. PubMed ID: 14631910
[TBL] [Abstract][Full Text] [Related]
18. Topical [symbol: see text] tacrolimus--a role in atopic dermatitis?
Drug Ther Bull; 2002 Oct; 40(10):73-5. PubMed ID: 12434738
[TBL] [Abstract][Full Text] [Related]
19. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
20. Topical tacrolimus in the treatment of atopic dermatitis.
Gianni LM; Sulli MM
Ann Pharmacother; 2001; 35(7-8):943-6. PubMed ID: 11485148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
